Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences|January 7, 2022
Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1-Contact vs R1 < 1 mm margin widthFabio Ausania, Filippo Landi, Aleix Martínez-Pérez, et al.
Endocrine-Related Cancer|December 26, 2008
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancerRosa Gallego, Jordi Codony-Servat, Xabier García-Albéniz, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 18, 2011
Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screeningSandra Pérez-Torras, Anna Vidal-Pla, Rosa Miquel, et al.
Investigational New Drugs|October 17, 2008
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patientsLisardo Ugidos, Salvadora Delgado, Carlos Conill, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 25, 2010
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximabXabier Garcia-Albeniz, Carles Pericay, Virginia Alonso-Espinaco, et al.
Cancer|September 1, 2005
A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on SarcomasXavier Garcia del Muro, Antonio Lopez-Pousa, Javier Martin, et al.
Medical Oncology (Northwood, London, England)|January 23, 2013
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancerJordi Codony-Servat, Xabier Garcia-Albeniz, Carles Pericay, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive <i>DPYD</i> Pharmacogenetic TestingMaría Rodríguez-García, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra, et al.
Plos One|January 14, 2014
A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) studyJorge Aparicio, Carmen García-Mora, Marta Martín, et al.
Reviews on Recent Clinical Trials|January 19, 2011
Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)Gemma Carrera, Xabier Garcia-Albeniz, Juan Ramón Ayuso, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Journal of Hepato-Biliary-Pancreatic Sciences|January 7, 2022
Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1-Contact vs R1 < 1 mm margin widthFabio Ausania, Filippo Landi, Aleix Martínez-Pérez, et al.
Endocrine-Related Cancer|December 26, 2008
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancerRosa Gallego, Jordi Codony-Servat, Xabier García-Albéniz, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 18, 2011
Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screeningSandra Pérez-Torras, Anna Vidal-Pla, Rosa Miquel, et al.
Investigational New Drugs|October 17, 2008
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patientsLisardo Ugidos, Salvadora Delgado, Carlos Conill, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 25, 2010
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximabXabier Garcia-Albeniz, Carles Pericay, Virginia Alonso-Espinaco, et al.
Cancer|September 1, 2005
A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on SarcomasXavier Garcia del Muro, Antonio Lopez-Pousa, Javier Martin, et al.
Medical Oncology (Northwood, London, England)|January 23, 2013
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancerJordi Codony-Servat, Xabier Garcia-Albeniz, Carles Pericay, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive <i>DPYD</i> Pharmacogenetic TestingMaría Rodríguez-García, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra, et al.
Plos One|January 14, 2014
A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) studyJorge Aparicio, Carmen García-Mora, Marta Martín, et al.
Reviews on Recent Clinical Trials|January 19, 2011
Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)Gemma Carrera, Xabier Garcia-Albeniz, Juan Ramón Ayuso, et al.
Pageof 12